SureTrader
Home > Boards > Free Zone > Health and Sciences > Biotech Values

ARRY: New 8K irt Genentech agreement. Expansion to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ThomasS Member Profile
 
Followed By 12
Posts 2,362
Boards Moderated 0
Alias Born 05/05/05
160x600 placeholder
Nasdaq Slammed As Rout In Tech Drives Stocks To Largest Weekly Drop In A Month
Nasdaq, S&P 500 post largest weekly drops in four A rout in tech stockshighlighted by LinkedIn Corp.'s massive drop after the...
Top Equities Stories Of The Day
Merck Posts Lower Revenue and Profit -- 2nd Update
Charter Communications Loss Widens on Merger Costs
Pay Dividends Or Keep Ratings
Online Retailers Find Stores Bring Customers to Web
Apple Ordered to Pay $625.6 Million in Patent Suit Vs VirnetX
Lehman and J.P. Morgan Seek Approval of $1.42 Billion Settlement -- Week Ahead
Wells To Pay $1.2 Billion In Mortgage Accord
Fox, Offering Buyouts, Targets $250 Million in Cost Cuts--Update
ThomasS   Monday, 09/08/08 07:36:58 AM
Re: None
Post # of 199560 
ARRY: New 8K irt Genentech agreement. Expansion to include a new target under the existing collaboration #msg-29627295:

Array BioPharma Inc. (the "Company") and Genentech, Inc. ("Genentech") have entered into an amendment effective as of September 1, 2008 (the "Amendment") to the Drug Discovery Collaboration Agreement between the Company and Genentech dated December 22, 2003, as amended (the "Agreement"). Under the Amendment, the Company and Genentech added a new collaboration target and agreed to increase the number of the Company's full-time equivalent scientists ("FTEs") performing services under the Agreement. Genentech continues to have the right to reduce the number of FTEs under the Agreement after January 1, 2010, subject to higher minimum levels set forth in the Amendment. The Amendment also provides for the payment of a one-time license fee, research funding and milestone payments to the Company in connection with the new target.

"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist